Related Experiment Video

Updated: Mar 22, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.3K

Epidemiology of Multimorbidity in Older Adults with Cardiovascular Disease

Susan P Bell1, Avantika A Saraf1

  • 1Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medicine Center, Nashville, TN, USA; Division of Geriatric Medicine, Center for Quality Aging, Vanderbilt University Medical Center, Nashville, TN, USA.

Clinics in Geriatric Medicine
|April 27, 2016
PubMed

Insights

Multimorbidity significantly impacts older adults, especially those with cardiovascular disease. Care must shift from single-disease approaches to patient-centered models to meet the needs of an aging population.

Area of Science:

  • Geriatric Medicine
  • Cardiovascular Disease Research
  • Health Services Research

Background:

  • Multimorbidity is a primary health concern for older adults, affecting all aspects of healthcare.
  • The prevalence of multimorbidity increases with age and significantly impacts cardiovascular disease management.
  • Current evidence-based treatments primarily focus on single cardiovascular conditions.

Purpose of the Study:

  • To highlight the profound impact of multimorbidity on cardiovascular disease presentation, diagnosis, management, and patient preferences.
  • To advocate for a paradigm shift in healthcare delivery for an aging population with multiple chronic conditions.

Main Methods:

  • Review of existing literature on multimorbidity and cardiovascular disease in older adults.
  • Analysis of the implications of multimorbidity on current healthcare practices and patient-centered care.

Main Results:

  • Multimorbidity complicates cardiovascular disease presentation and management.
  • Existing therapeutic strategies are often disease-specific, inadequately addressing complex patient needs.
  • A significant increase in the older adult population is projected, exacerbating the need for integrated care.

Conclusions:

  • A patient-centered care framework is essential to address the complexities of multimorbidity in older adults.
  • Healthcare systems must adapt to manage multiple chronic conditions effectively.
  • Future research and clinical practice should prioritize holistic, patient-centered approaches for geriatric populations.

Keywords:
Cardiovascular diseaseChronic conditionsMultimorbidityOlder adults

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K
Multi-Modal Home Sleep Monitoring in Older Adults07:40

Multi-Modal Home Sleep Monitoring in Older Adults

Published on: January 26, 2019

8.3K

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
312
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
653
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
545
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
958
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
821
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
314